Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CA77.1(CA) is a novel chaperon-mediated autophagy (CMA) activator for the treatment of Alzheimer's disease (AD).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 52.00 | |
10 mg | In stock | $ 85.00 | |
25 mg | In stock | $ 166.00 | |
50 mg | In stock | $ 263.00 | |
100 mg | In stock | $ 409.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 58.00 |
Description | CA77.1(CA) is a novel chaperon-mediated autophagy (CMA) activator for the treatment of Alzheimer's disease (AD). |
Molecular Weight | 297.74 |
Formula | C16H12ClN3O |
CAS No. | 2412270-22-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.98 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CA77.1 2412270-22-3 Autophagy CA-77.1 CMA Inhibitor LAMP2A inhibit alzheimer's?disease derivative neuropathology KFERQ inhibitor